Evaluation demonstrates CBD nano-cream reduces psoriasis symptoms in UVB-induced Wistar rats, suggesting a therapeutic potential.
Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferation of keratinocytes, immune cell infiltration, and erythematous plaques. This study aimed to evaluate the therapeutic efficacy of a cannabidiol (CBD) nano-cream in a UVB-induced psoriasis rat model. The nano-cream was formulated using a nanoemulsion-based system to enhance dermal delivery and sustained release of CBD. Characterization studies confirmed optimal pH, viscosity, spreadability, and high drug content. The anti-psoriatic potential was assessed by evaluating histopathological changes, Psoriasis Area Severity Index (PASI), and epidermal thickness in Wistar rats exposed to UVB radiation. Results demonstrated that the CBD nano-cream significantly reduced inflammation, erythema, and epidermal hyperplasia compared to control groups. The findings support the potential of CBD nano-cream as a promising topical therapeutic approach for the treatment of psoriasis.
No takes yet. Share an insight, caveat, or question.
Vaghela et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: